{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/d216e525-3568-4f94-b402-8a3eaa1ad260/63482671a5451a001237cbc1?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Flat urothelial lesions of the urinary bladder: Who is in who is out?","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9f39f1a8cbe7bbf3cedc6/show-cover.png?height=200","description":"<p>Flat lesions of the urothelium with histologic features that falls short of the threshold for urothelial carcinoma in situ (CIS) remains a challenging problem in diagnostic surgical pathology. Among these are flat urothelial hyperplasia, urothelial dysplasia, and atypia of unknown significance; lesions that have struggled under evolving classifications, changing criteria, and limited clinical actionability, all confounded by the recognized lack of diagnostic reproducibility. </p><p> In this episode of ModPath Chat, Dr. Gladell Paner discusses with the host his recently published “Controversies in Pathology” article in <em>Modern Pathology</em> on the pros and cons of keeping the previous terminology of this group of lesions.&nbsp;</p>","author_name":"Modern Pathology"}